Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion type Assertion NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_head.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion description "[Inhibiting antiapoptotic BCL-2 and its relatives is an attractive strategy for sensitizing lymphoid malignancies to drugs but it has been largely unsuccessful for melanoma and other solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion evidence source_evidence_literature NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion SIO_000772 22173547 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion wasDerivedFrom befree-20150227 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.
- NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_assertion wasGeneratedBy ECO_0000203 NP263214.RAYGEaAqsucU2INK8Fh5-_xvtdGjk54HxP1iBLk_-WcvE130_provenance.